723 related articles for article (PubMed ID: 30357841)
1. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
[TBL] [Abstract][Full Text] [Related]
2. Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs.
Saltarella I; Lamanuzzi A; Desantis V; Di Marzo L; Melaccio A; Curci P; Annese T; Nico B; Solimando AG; Bartoli G; Tolomeo D; Storlazzi CT; Mariggiò MA; Ria R; Musto P; Vacca A; Frassanito MA
J Pathol; 2022 Apr; 256(4):402-413. PubMed ID: 34919276
[TBL] [Abstract][Full Text] [Related]
3. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
4. Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.
Desantis V; Frassanito MA; Tamma R; Saltarella I; Di Marzo L; Lamanuzzi A; Solimando AG; Ruggieri S; Annese T; Nico B; Vacca A; Ribatti D
Ann Hematol; 2018 Jul; 97(7):1251-1258. PubMed ID: 29589107
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
[TBL] [Abstract][Full Text] [Related]
6. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
Zhang HW; Shi Y; Liu JB; Wang HM; Wang PY; Wu ZJ; Li L; Gu LP; Cao PS; Wang GR; Ma YS; Fu D
J Cell Mol Med; 2021 Apr; 25(8):3699-3713. PubMed ID: 33621425
[TBL] [Abstract][Full Text] [Related]
9. miR-17-3p promotes the proliferation of multiple myeloma cells by downregulating P21 expression through LMLN inhibition.
Xiang P; Yeung YT; Wang J; Wu Q; Du R; Huang C; Jia X; Gao Y; Zhi Y; Guo F; Wei H; Zhang D; Liu Y; Liu L; Liang L; Wang J; Song Y; Liu K; Fang B
Int J Cancer; 2021 Jun; 148(12):3071-3085. PubMed ID: 33609405
[TBL] [Abstract][Full Text] [Related]
10. Transferred by exosomes-derived MiR-19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration and invasion.
Zeng Q; Zhu Z; Song L; He Z
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146702
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
[TBL] [Abstract][Full Text] [Related]
12. miR-101-loaded exosomes secreted by bone marrow mesenchymal stem cells requires the FBXW7/HIF1α/FOXP3 axis, facilitating osteogenic differentiation.
Li Y; Wang J; Ma Y; Du W; Feng K; Wang S
J Cell Physiol; 2021 Jun; 236(6):4258-4272. PubMed ID: 33438204
[TBL] [Abstract][Full Text] [Related]
13. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway.
Hou K; Li G; Zhao J; Xu B; Zhang Y; Yu J; Xu K
J Neuroinflammation; 2020 Feb; 17(1):46. PubMed ID: 32014002
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway.
Wen Z; Mai Z; Zhu X; Wu T; Chen Y; Geng D; Wang J
Stem Cell Res Ther; 2020 Jan; 11(1):36. PubMed ID: 31973741
[TBL] [Abstract][Full Text] [Related]
15. microRNA-423-3p exosomes derived from cardiac fibroblasts mediates the cardioprotective effects of ischaemic post-conditioning.
Luo H; Li X; Li T; Zhao L; He J; Zha L; Qi Q; Yu Z
Cardiovasc Res; 2019 Jun; 115(7):1189-1204. PubMed ID: 30202848
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.
Peng Y; Song X; Lan J; Wang X; Wang M
Medicine (Baltimore); 2021 Jan; 100(4):e23447. PubMed ID: 33530159
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Zhang X; Chen Y; Zhao P; Zang L; Zhang Z; Wang X
Leuk Lymphoma; 2017 Apr; 58(4):932-940. PubMed ID: 27830963
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
[TBL] [Abstract][Full Text] [Related]
20. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis.
Gámez B; Edwards CM
Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
